SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-030606
Filing Date
2019-05-16
Accepted
2019-05-16 18:34:36
Documents
2
Period of Report
2019-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1501
2 EX-24 DOCUMENT attachment1.htm EX-24 2590
  Complete submission text file 0001209191-19-030606.txt   5439
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 42 WHITE STREET, FOURTH FLOOR NEW YORK NY 10013
Business Address
SCHAFER CAROL (Reporting) CIK: 0001272181 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36070 | Film No.: 19833683